Leading with the LNA
Why Santaris opted for an acquisition by Roche over JOBS Act IPO
Given a choice between an acquisition and taking a chance on an IPO, investors in Santaris Pharma A/S took the path of certainty offered by partner Roche (SIX:ROG; OTCQX:RHHBY). They will net a greater than 2x return based on the upfront payment alone.
Last week, the
